| Product Code: ETC12942915 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mauritius mRNA Vaccines and Therapeutics Market Overview |
3.1 Mauritius Country Macro Economic Indicators |
3.2 Mauritius mRNA Vaccines and Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Mauritius mRNA Vaccines and Therapeutics Market - Industry Life Cycle |
3.4 Mauritius mRNA Vaccines and Therapeutics Market - Porter's Five Forces |
3.5 Mauritius mRNA Vaccines and Therapeutics Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Mauritius mRNA Vaccines and Therapeutics Market Revenues & Volume Share, By Therapeutic Type, 2021 & 2031F |
3.7 Mauritius mRNA Vaccines and Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Mauritius mRNA Vaccines and Therapeutics Market Revenues & Volume Share, By Delivery Method, 2021 & 2031F |
3.9 Mauritius mRNA Vaccines and Therapeutics Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Mauritius mRNA Vaccines and Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Mauritius mRNA Vaccines and Therapeutics Market Trends |
6 Mauritius mRNA Vaccines and Therapeutics Market, By Types |
6.1 Mauritius mRNA Vaccines and Therapeutics Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Mauritius mRNA Vaccines and Therapeutics Market Revenues & Volume, By Vaccine Type, 2021 - 2031F |
6.1.3 Mauritius mRNA Vaccines and Therapeutics Market Revenues & Volume, By COVID-19 Vaccine, 2021 - 2031F |
6.1.4 Mauritius mRNA Vaccines and Therapeutics Market Revenues & Volume, By Influenza Vaccine, 2021 - 2031F |
6.1.5 Mauritius mRNA Vaccines and Therapeutics Market Revenues & Volume, By Rabies Vaccine, 2021 - 2031F |
6.1.6 Mauritius mRNA Vaccines and Therapeutics Market Revenues & Volume, By Zika Virus Vaccine, 2021 - 2031F |
6.1.7 Mauritius mRNA Vaccines and Therapeutics Market Revenues & Volume, By CMV Vaccine, 2021 - 2031F |
6.2 Mauritius mRNA Vaccines and Therapeutics Market, By Therapeutic Type |
6.2.1 Overview and Analysis |
6.2.2 Mauritius mRNA Vaccines and Therapeutics Market Revenues & Volume, By Cancer Immunotherapy, 2021 - 2031F |
6.2.3 Mauritius mRNA Vaccines and Therapeutics Market Revenues & Volume, By Personalized Cancer Vaccine, 2021 - 2031F |
6.2.4 Mauritius mRNA Vaccines and Therapeutics Market Revenues & Volume, By Protein Replacement Therapy, 2021 - 2031F |
6.2.5 Mauritius mRNA Vaccines and Therapeutics Market Revenues & Volume, By Autoimmune Disease Treatment, 2021 - 2031F |
6.2.6 Mauritius mRNA Vaccines and Therapeutics Market Revenues & Volume, By mRNA-Based Drug Delivery, 2021 - 2031F |
6.3 Mauritius mRNA Vaccines and Therapeutics Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Mauritius mRNA Vaccines and Therapeutics Market Revenues & Volume, By Infectious Diseases, 2021 - 2031F |
6.3.3 Mauritius mRNA Vaccines and Therapeutics Market Revenues & Volume, By Oncology, 2021 - 2031F |
6.3.4 Mauritius mRNA Vaccines and Therapeutics Market Revenues & Volume, By Genetic Disorders, 2021 - 2031F |
6.3.5 Mauritius mRNA Vaccines and Therapeutics Market Revenues & Volume, By Neurological Disorders, 2021 - 2031F |
6.3.6 Mauritius mRNA Vaccines and Therapeutics Market Revenues & Volume, By Cardiovascular Diseases, 2021 - 2031F |
6.4 Mauritius mRNA Vaccines and Therapeutics Market, By Delivery Method |
6.4.1 Overview and Analysis |
6.4.2 Mauritius mRNA Vaccines and Therapeutics Market Revenues & Volume, By Intramuscular Injection, 2021 - 2031F |
6.4.3 Mauritius mRNA Vaccines and Therapeutics Market Revenues & Volume, By Subcutaneous Injection, 2021 - 2031F |
6.4.4 Mauritius mRNA Vaccines and Therapeutics Market Revenues & Volume, By Intradermal Injection, 2021 - 2031F |
6.4.5 Mauritius mRNA Vaccines and Therapeutics Market Revenues & Volume, By Intravenous Infusion, 2021 - 2031F |
6.4.6 Mauritius mRNA Vaccines and Therapeutics Market Revenues & Volume, By Oral Delivery, 2021 - 2031F |
6.5 Mauritius mRNA Vaccines and Therapeutics Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 Mauritius mRNA Vaccines and Therapeutics Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.5.3 Mauritius mRNA Vaccines and Therapeutics Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.5.4 Mauritius mRNA Vaccines and Therapeutics Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.5.5 Mauritius mRNA Vaccines and Therapeutics Market Revenues & Volume, By Biotechnology Firms, 2021 - 2031F |
6.5.6 Mauritius mRNA Vaccines and Therapeutics Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
7 Mauritius mRNA Vaccines and Therapeutics Market Import-Export Trade Statistics |
7.1 Mauritius mRNA Vaccines and Therapeutics Market Export to Major Countries |
7.2 Mauritius mRNA Vaccines and Therapeutics Market Imports from Major Countries |
8 Mauritius mRNA Vaccines and Therapeutics Market Key Performance Indicators |
9 Mauritius mRNA Vaccines and Therapeutics Market - Opportunity Assessment |
9.1 Mauritius mRNA Vaccines and Therapeutics Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Mauritius mRNA Vaccines and Therapeutics Market Opportunity Assessment, By Therapeutic Type, 2021 & 2031F |
9.3 Mauritius mRNA Vaccines and Therapeutics Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Mauritius mRNA Vaccines and Therapeutics Market Opportunity Assessment, By Delivery Method, 2021 & 2031F |
9.5 Mauritius mRNA Vaccines and Therapeutics Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Mauritius mRNA Vaccines and Therapeutics Market - Competitive Landscape |
10.1 Mauritius mRNA Vaccines and Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Mauritius mRNA Vaccines and Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here